Ovarian cancers arising from endometriosis: A microenvironmental biomarker study including ER, HNF1β, p53, PTEN, BAF250a, and COX-2

被引:27
作者
Lai, Chiung-Ru [1 ,2 ]
Hsu, Chih-Yi [1 ,2 ]
Chen, Yi-Jen [2 ,3 ]
Yen, Ming-Shyen [2 ,3 ]
Chao, Kuan-Chong [2 ,3 ]
Li, Anna Fen-Yau [1 ,2 ]
机构
[1] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Dept Pathol, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei 112, Taiwan
关键词
biomarkers; endometriosis; ovarian neoplasms; CLEAR-CELL CARCINOMA; CYCLOOXYGENASE-2; EXPRESSION; POOR-PROGNOSIS; MUTATIONS; ARID1A; RISK; EPIDEMIOLOGY; DIAGNOSIS; TISSUE; COHORT;
D O I
10.1016/j.jcma.2013.07.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The microenvironmental biomarkers of different subtypes of ovarian cancers arising from endometriosis have not been studied in Taiwan. Their expression can help in understanding the carcinogenic mechanism. Methods: Our study used immunohistochemistry to compare the expression of estrogen receptor (ER), hepatocyte nuclear factor-1 beta (HNF1 beta), p53, phosphatase and tensin homolog (PTEN), BAF250a, and cyclooxygenase-2 (COX-2) among 79 cases of endometriosis-associated ovarian cancers, including 40 (50%) clear cell carcinomas (CCCs), 33 (41%) endometrioid (EM) adenocarcinomas, four (5%) serous carcinomas, one adenosquamous carcinoma, and one adenosarcoma. Results: Positive stainings for ER, HNF1 beta, p53, and COX-2 were identified in 34 (43%), 30 (38%), 10 (13%), and 44 (56%) cases. Loss of PTEN and BAF250a were noted in 29 (37%) and 37 (47%) cases. The expression of ER was reversely correlated with that of HNF1 beta (rho = -0.417, p < 0.001) and correlated with p53 (rho = 0.284, p = 0.011). ER positivity was commonly identified in EM adenocarcinomas (91%), and rarely in CCCs (8%) and serous carcinoma (0%; p < 0.001). By contrast, HNF1 beta expression was frequently noted in CCCs (65%) and serous carcinomas (50%), but less in EM adenocarcinoma (6%; p < 0.001). All staining results were similar between atypical endometriosis glandular epithelium and contiguous malignant parts. Only nine cases showed 10 minor differences (10/474, 2%) in ER, HNF1 beta, and BAF250a. For the staining patterns of p53, COX-2, and PTEN, there was no difference between the invasive and precursor parts. Conclusion: Our results supported the suggestion that estrogen-dependent ovarian cancer arising from endometriosis is substantially more associated with EM adenocarcinoma than CCCs. The positive HNF1 beta staining was a frequent finding in CCCs, but not in EM adenocarcinoma. The similar staining patterns of atypical endometriosis glandular cells with the invasive parts confirmed their precursor status. Copyright (C) 2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
引用
收藏
页码:629 / 634
页数:6
相关论文
共 30 条
[1]   Interpretation of p53 immunoreactivity in endometrial carcinoma: Establishing a clinically relevant cut-off level [J].
Alkushi, A ;
Lim, P ;
Coldman, A ;
Huntsman, D ;
Miller, D ;
Gilks, CB .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2004, 23 (02) :129-137
[2]   Endometriosis-associated ovarian cancer: A ten-year cohort study of women living in the Estrie Region of Quebec, Canada [J].
Aris, Aziz .
JOURNAL OF OVARIAN RESEARCH, 2010, 3
[3]   Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis [J].
Borgfeldt, C ;
Andolf, E .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (04) :395-400
[4]   Up-Regulation of Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Endometriotic Cells by Macrophage Migration Inhibitory Factor: Involvement of Novel Kinase Signaling Pathways [J].
Carli, Cedric ;
Metz, Christine N. ;
Al-Abed, Yousef ;
Naccache, Paul H. ;
Akoum, Ali .
ENDOCRINOLOGY, 2009, 150 (07) :3128-3137
[5]   Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis [J].
Chou, YC ;
Chen, YJ ;
Lai, CR ;
Wang, PH ;
Hsin-Chan ;
Yuan, CC .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 124 (01) :101-105
[6]   Morphologic Spectrum of Immunohistochemically Characterized Clear Cell Carcinoma of the Ovary: A Study of 155 Cases [J].
DeLair, Deborah ;
Oliva, Esther ;
Koebel, Martin ;
Macias, Antonio ;
Gilks, C. Blake ;
Soslow, Robert A. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (01) :36-44
[7]   Epidemiology of endometriosis [J].
Eskenazi, B ;
Warner, ML .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1997, 24 (02) :235-+
[8]   Clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease [J].
Goff, BA ;
delaCuesta, RS ;
Muntz, HG ;
Fleischhacker, D ;
Ek, M ;
Rice, LW ;
Nikrui, N ;
Tamimi, HK ;
Cain, JM ;
Greer, BE ;
Fuller, AF .
GYNECOLOGIC ONCOLOGY, 1996, 60 (03) :412-417
[9]   Ovarian clear cell carcinoma-bad endometriosis or bad endometrium? [J].
Gounaris, Ioannis ;
Charnock-Jones, D. Stephen ;
Brenton, James D. .
JOURNAL OF PATHOLOGY, 2011, 225 (02) :157-160
[10]   Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma [J].
Jones, Sian ;
Wang, Tian-Li ;
Shih, Ie-Ming ;
Mao, Tsui-Lien ;
Nakayama, Kentaro ;
Roden, Richard ;
Glas, Ruth ;
Slamon, Dennis ;
Diaz, Luis A., Jr. ;
Vogelstein, Bert ;
Kinzler, Kenneth W. ;
Velculescu, Victor E. ;
Papadopoulos, Nickolas .
SCIENCE, 2010, 330 (6001) :228-231